PIERIS PHARMACEUTICALS INC - COM (PIRS) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q3 2024

Type / Class
Equity / COM
Symbol
PIRS on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$2,402 0
2024 Q2 14,000 $2,402 -$6,904,333 $0.17 1
2024 Q1 37,707,385 $6,906,898 -$138,911 $0.18 37
2023 Q4 38,492,518 $7,004,252 -$733,987 $0.18 42
2023 Q3 40,347,295 $12,022,694 -$1,415,553 $0.30 39
2023 Q2 48,596,995 $8,041,768 -$5,167,205 $0.17 44
2023 Q1 34,246,696 $33,405,987 -$1,152,067 $0.98 60
2022 Q4 35,408,066 $36,820,948 +$306,656 $1.04 61
2022 Q3 34,887,941 $40,122,000 -$2,048,598 $1.15 61
2022 Q2 36,559,637 $68,366,000 -$5,960,260 $1.87 64
2022 Q1 37,934,408 $114,943,120 +$6,273,710 $3.03 70
2021 Q4 35,908,129 $135,783,828 +$11,882,972 $3.78 78
2021 Q3 31,885,518 $164,846,363 +$29,559,303 $5.17 73
2021 Q2 26,647,807 $102,050,163 -$15,806,173 $3.83 73
2021 Q1 32,172,941 $82,298,406 -$3,323,203 $2.57 80
2020 Q4 33,475,973 $83,694,086 +$622,468 $2.50 80
2020 Q3 33,291,552 $68,910,783 -$5,673,578 $2.07 86
2020 Q2 34,496,145 $107,122,277 -$9,334,525 $3.10 94
2020 Q1 35,340,326 $80,563,689 +$1,950,129 $2.28 91
2019 Q4 35,578,662 $128,584,918 +$23,475,156 $3.62 96
2019 Q3 28,402,616 $96,861,638 -$995,213 $3.41 98
2019 Q2 27,421,887 $128,747,997 -$3,495,757 $4.70 92
2019 Q1 29,549,103 $98,959,350 -$17,232,040 $3.35 92
2018 Q4 34,968,627 $92,990,751 -$9,242,474 $2.66 97
2018 Q3 35,560,418 $199,105,798 +$2,035,527 $5.60 105
2018 Q2 35,253,436 $178,752,903 -$8,412,504 $5.07 113
2018 Q1 33,325,837 $227,166,543 +$71,963,498 $6.82 112
2017 Q4 23,698,036 $178,924,301 +$8,204,480 $7.55 90
2017 Q3 22,595,315 $130,172,308 +$628,910 $5.76 65
2017 Q2 22,512,497 $113,912,216 +$16,002,650 $5.06 47
2017 Q1 19,415,375 $50,480,000 -$147,781 $2.60 26
2016 Q4 20,137,440 $28,256,000 -$554,729 $1.40 23
2016 Q3 20,474,081 $37,445,000 +$1,412,200 $1.83 29
2016 Q2 19,710,379 $31,735,000 +$3,699,293 $1.61 24
2016 Q1 17,414,315 $33,088,000 -$590,753 $1.90 15
2015 Q4 17,690,231 $40,509,000 -$1,373,440 $2.29 18
2015 Q3 18,480,416 $33,820,000 +$3,059,025 $1.83 13
2015 Q2 16,940,081 $46,587,000 +$45,349,000 $2.75 13